Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure [Yahoo! Finance]
Zhengye Biotechnology Holding Limited (ZYBT)
Company Research
Source: Yahoo! Finance
Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced the implementation of a dual-class share structure, effective April 7, 2026. At the annual general meeting of shareholders held on March 24, 2026, the Company's shareholders approved the introduction of two classes of ordinary shares, designated as Class A and Class B. The Company's Class A ordinary shares are expected to begin trading on the Nasdaq Capital Market at the open of business on April 7, 2026, continuing under the ticker symbol “ZYBT.” While the CUSIP number will remain the same, the CUSIP description will be updated to reflect the new designation as Class A ordinary shares. Pursuant to the dual-class share structure, the Company's authorized share capital of US$50,000 is re-designated and re-classified into 2,000,000,000 ordinary share
Show less
Read more
Impact Snapshot
Event Time:
ZYBT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYBT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYBT alerts
High impacting Zhengye Biotechnology Holding Limited news events
Weekly update
A roundup of the hottest topics
ZYBT
News
- Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share StructureGlobeNewswire
- Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to ShareholdersGlobeNewswire
- Zhengye Biotechnology (NASDAQ:ZYBT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
ZYBT
Sec Filings
- 3/25/26 - Form 6-K
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- ZYBT's page on the SEC website